Source: Lumiera Health Inc.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Lumiera Health (NHP) has signed an MoU to explore a strategic partnership with one of Quebec’s leaders in the natural health industry
  • The MoU will set guidelines for an agreement allowing both Lumiera and its partner to manufacture and sell white label products from their respective portfolio to each other
  • The agreement would provide Lumiera with access to a broad range of products in Natural Health retail stores
  • Lumiera specializes in the development and commercialization of consumer products for the natural health industry
  • Lumiera Health opened trading at C$0.015

Lumiera Health (NHP) has signed an MoU to explore a strategic partnership with one of Quebec’s leaders in the natural health industry.

The purpose of the MoU is to set the guidelines to discuss an eventual agreement that would allow both Lumiera and its Partner to manufacture and sell white label products from their respective portfolio to each other. The potential agreement would include a mutually exclusive supplier agreement, as well as minimum quantity requirements and exclusivity in certain sales channels.

The partner company has been an established leader in Quebec’s Natural Health industry for over 75 years and has a strong presence in the Pharmacy and Big Box retail channels.

Carlos Ponce, CEO of Lumiera, commented on the news.

“This potential partnership is an incredible opportunity for Lumiera. By leveraging our partner’s considerable brand equity and distribution in high-volume retail channels, we can accelerate our growth exponentially. Furthermore, this would give Lumiera access to a broad range of products that have enormous potential in Natural Health retail stores.”

Lumiera specializes in the development and commercialization of consumer products for the natural health industry.

Lumiera Health opened trading at C$0.015.


More From The Market Herald

" Voyageur (TSXV:VM) completes SmoothX testing

Voyageur Pharmaceuticals (VM) has completed the production test batch of its SmoothX product for the computerized tomography (CT) imaging market in Canada.
Aleafia Health - CEO, Tricia Symmes

" Aleafia Health (TSX:AH) completes TSX review and enters fifth province

Aleafia Health (AH) has completed the TSX delisting review and has satisfied the Toronto Stock Exchange’s requirements for continued listing.

" Alpha Cognition (TSXV:ACOG) withdraws public offering

Alpha Cognition (ACOG) has withdrawn its previously-announced marketed public offering.
Bright Mind Biosciences - CEO, Ian McDonald

" Bright Minds Biosciences (CSE:DRUG) announces non-brokered private placement

Bright Minds Biosciences (DRUG) has announced a non-brokered private placement of gross proceeds of $2,050,000.